| Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease EF Fang, Y Hou, K Palikaras, BA Adriaanse, JS Kerr, B Yang, S Lautrup, ... Nature neuroscience 22 (3), 401-412, 2019 | 1164 | 2019 |
| Mitophagy and Alzheimer’s disease: cellular and molecular mechanisms JS Kerr, BA Adriaanse, NH Greig, MP Mattson, MZ Cader, VA Bohr, ... Trends in neurosciences 40 (3), 151-166, 2017 | 670 | 2017 |
| Rapamycin in ischemic stroke: Old drug, new tricks? G Hadley, DJ Beard, Y Couch, AA Neuhaus, BA Adriaanse, GC DeLuca, ... Journal of Cerebral Blood Flow & Metabolism 39 (1), 20-35, 2019 | 47 | 2019 |
| The role of the endoplasmic reticulum stress response following cerebral ischemia G Hadley, AA Neuhaus, Y Couch, DJ Beard, BA Adriaanse, K Vekrellis, ... International journal of stroke 13 (4), 379-390, 2018 | 30 | 2018 |
| Culprit or bystander: defective mitophagy in Alzheimer’s disease C Xie, Y Aman, BA Adriaanse, MZ Cader, H Plun-Favreau, J Xiao, ... Frontiers in Cell and Developmental Biology 7, 391, 2020 | 16 | 2020 |
| Tuberous sclerosis complex‐1 (TSC1) contributes to selective neuronal vulnerability in Alzheimer's disease BA Adriaanse, S Brady, M Wang, DJ Beard, JI Spencer, J Pansieri, ... Neuropathology and Applied Neurobiology 49 (3), e12904, 2023 | 2 | 2023 |
| Rapamycin Treatment Reduces Brain Pericyte Constriction in Ischemic Stroke D Beard, LS Brown, GP Morris, Y Couch, BA Adriaanse, ... bioRxiv, 2024.03. 18.584333, 2024 | | 2024 |
| The role of the TSC-complex in selective neuronal vulnerability in Alzheimer’s disease B Adriaanse University of Oxford, 2019 | | 2019 |
